Skip to main content

Table 1 A chart showing drug administration regimens

From: The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial

Treatment

Groups

Experimental group

Control group

CCRT (6 weeks)

RT

2.0Gy once daily, 5 days per week

TMZ

A daily dose of 75 mg/m2

LEV

500 mg, twice daily

Placebo tablets

Adjuvant chemotherapy (6 cycles)

TMZ

A daily dose of 100–200 mg/m2

LEV

200–1500 mg, twice daily

Placebo tablets

  1. Abbreviations: 1 cycle, 28 days; RT, Radiation therapy, CCRT Concurrent chemoradiotherapy